Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Guyton

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|July 9, 2020
Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitisMargery A Connelly, Jonathan Velez Rivera, John R Guyton, et al.
Journal of Lipid Research|January 1, 1987
Isolation and characterization of the two major apoproteins in human lipoprotein [a]J W Gaubatz, M V Chari, M L Nava, et al.
Annals of Internal Medicine|May 19, 2004
A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trialWilliam S Yancy, Maren K Olsen, John R Guyton, et al.
Diabetes, Obesity & Metabolism|October 1, 2010
Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndromeS Fazio, J R Guyton, J Lin, et al.
Journal of Clinical Lipidology|June 19, 2021
JCL Roundtable: Global Think Tank on Lipoprotein(a)Lisa L Maher, S Lale Tokgözoğlu, Eduardo J Sanchez, et al.
Journal of Clinical Lipidology|May 4, 2019
JCL roundtable: Lipid treatment targetsDebra A Friedrich, Dean G Karalis, Karen E Aspry, et al.
Atherosclerosis|July 25, 2013
Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemiaMichel Farnier, John R Guyton, Erin Jensen, et al.
Journal of the American College of Cardiology|April 19, 2008
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemiaJohn R Guyton, B Greg Brown, Sergio Fazio, et al.
Current Diabetes Reports|February 27, 2019
Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in DiabetesAnastasia-Stefania Alexopoulos, Ali Qamar, Kathryn Hutchins, et al.
Artery|January 1, 1994
Amiprilose hydrochloride inhibits porcine aortic smooth muscle cell proliferation in vitroC O Siegel, D A Churchill, L Vu, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|July 9, 2020
Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitisMargery A Connelly, Jonathan Velez Rivera, John R Guyton, et al.
Journal of Lipid Research|January 1, 1987
Isolation and characterization of the two major apoproteins in human lipoprotein [a]J W Gaubatz, M V Chari, M L Nava, et al.
Annals of Internal Medicine|May 19, 2004
A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trialWilliam S Yancy, Maren K Olsen, John R Guyton, et al.
Diabetes, Obesity & Metabolism|October 1, 2010
Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndromeS Fazio, J R Guyton, J Lin, et al.
Journal of Clinical Lipidology|June 19, 2021
JCL Roundtable: Global Think Tank on Lipoprotein(a)Lisa L Maher, S Lale Tokgözoğlu, Eduardo J Sanchez, et al.
Journal of Clinical Lipidology|May 4, 2019
JCL roundtable: Lipid treatment targetsDebra A Friedrich, Dean G Karalis, Karen E Aspry, et al.
Atherosclerosis|July 25, 2013
Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemiaMichel Farnier, John R Guyton, Erin Jensen, et al.
Journal of the American College of Cardiology|April 19, 2008
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemiaJohn R Guyton, B Greg Brown, Sergio Fazio, et al.
Current Diabetes Reports|February 27, 2019
Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in DiabetesAnastasia-Stefania Alexopoulos, Ali Qamar, Kathryn Hutchins, et al.
Artery|January 1, 1994
Amiprilose hydrochloride inhibits porcine aortic smooth muscle cell proliferation in vitroC O Siegel, D A Churchill, L Vu, et al.
Pageof 17